More than half a million doses of Sanofi’s meningococcal vaccine, Menactra, have arrived in Australia The vaccine is indicated for people from two through to 55 years, to protect against meningococcal disease caused by four groups of Neisseria meningitides—A, C, Y and W-135. Auspharm forum members discussed their problems accessing stock back in March. Russell
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.